Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250023-08-000023
Filing Date
2008-06-12
Accepted
2008-06-12 18:31:29
Documents
1
Period of Report
2008-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4202
  Complete submission text file 0001250023-08-000023.txt   6071
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

EIN.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076
Business Address 7704429707
SAXE JON S (Reporting) CIK: 0001114914 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 08896813